Integral Ad Science (NASDAQ:IAS) Stock Rating Reaffirmed by Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Integral Ad Science (NASDAQ:IAS) in a report released on Tuesday, MarketBeat Ratings reports. The firm currently has a $12.00 target price on the stock, down from their prior target price of $18.00.

A number of other analysts have also issued reports on the company. Truist Financial cut their target price on Integral Ad Science from $26.00 to $17.00 and set a buy rating on the stock in a research report on Wednesday, February 28th. Barclays cut their price objective on Integral Ad Science from $16.00 to $12.00 and set an equal weight rating on the stock in a research report on Monday. Piper Sandler cut their price objective on Integral Ad Science from $20.00 to $18.00 and set an overweight rating on the stock in a research report on Wednesday, February 28th. Bank of America initiated coverage on Integral Ad Science in a research report on Thursday, January 11th. They set a buy rating and a $19.00 price objective on the stock. Finally, Oppenheimer cut their price objective on Integral Ad Science from $25.00 to $20.00 and set an outperform rating on the stock in a research report on Wednesday, February 28th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus target price of $17.58.

Integral Ad Science Stock Down 2.9 %

Shares of NASDAQ IAS opened at $9.10 on Tuesday. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of 227.56, a PEG ratio of 1.65 and a beta of 1.60. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17. Integral Ad Science has a 52-week low of $9.08 and a 52-week high of $20.88. The business’s 50 day moving average is $11.42 and its two-hundred day moving average is $13.04.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The company had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. The firm’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.07 earnings per share. Research analysts predict that Integral Ad Science will post 0.16 EPS for the current year.

Insider Activity at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 13,113 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total value of $207,054.27. Following the transaction, the chief executive officer now owns 148,657 shares of the company’s stock, valued at $2,347,294.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Integral Ad Science news, CFO Tania Secor sold 6,570 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $9.71, for a total value of $63,794.70. Following the completion of the transaction, the chief financial officer now owns 230,888 shares in the company, valued at $2,241,922.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Lisa Utzschneider sold 13,113 shares of the company’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the transaction, the chief executive officer now owns 148,657 shares of the company’s stock, valued at approximately $2,347,294.03. The disclosure for this sale can be found here. Insiders have sold 80,195 shares of company stock valued at $876,562 over the last quarter. 2.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Integral Ad Science

Several hedge funds have recently made changes to their positions in IAS. Wellington Management Group LLP boosted its stake in shares of Integral Ad Science by 15,557.5% during the first quarter. Wellington Management Group LLP now owns 3,152,174 shares of the company’s stock worth $43,500,000 after buying an additional 3,132,042 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Integral Ad Science by 605.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after buying an additional 2,351,414 shares during the period. Vanguard Group Inc. boosted its stake in shares of Integral Ad Science by 77.2% during the third quarter. Vanguard Group Inc. now owns 4,752,765 shares of the company’s stock worth $34,409,000 after buying an additional 2,070,907 shares during the period. abrdn plc acquired a new stake in shares of Integral Ad Science during the fourth quarter worth about $25,285,000. Finally, Alliancebernstein L.P. raised its holdings in Integral Ad Science by 1,825.9% during the second quarter. Alliancebernstein L.P. now owns 943,681 shares of the company’s stock worth $16,967,000 after purchasing an additional 894,681 shares in the last quarter. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.